Author

B. Keegan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Plant Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Organism:C. elegans· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. C. de Araujo Leao· 2 shared B. Zhan· 2 shared C. Poveda· 2 shared D. Vergara· 2 shared J. Altieri Rivera· 2 shared J. Lee· 2 shared J. Pollet· 2 shared J. Wei· 2 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. C. de Araujo Leao

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The Phytochemical Diversity of Commercial Cannabis in the United States

C. J. Smith, D. Vergara, B. Keegan, N. Jikomes

This study analyzes the cannabinoid and terpene content of commercial Cannabis samples in the US, revealing distinct chemotypes that do not consistently align with commercial labels.

bioRxiv · Jul 5, 2021 · PreprintPlant Biology

Genetic Modification to Design a Stable Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain as a COVID-19 Vaccine Candidate

W.-H. Chen, J. Wei, R. T. Kundu, R. Adhikari, Z. Liu, J. Lee, L. Versteeg, C. Poveda, B. Keegan, M. J. Villar, A. C. de Araujo Leao, J. Altieri Rivera, P. M. Gillespie, J. Pollet, U. Strych, , M. E. Bottazzi

The paper genetically modifies SARS-CoV-2 RBD variants in yeast to identify a more stable and manufacturable vaccine candidate.

bioRxiv · Nov 9, 2020Immunology

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice

J. Pollet, W.-H. Chen, L. Versteeg, B. Keegan, B. Zhan, J. Wei, Z. Liu, J. Lee, R. Kundu, R. Adhikari, C. Poveda, M. J. Villar Mondragon, A. C. de Araujo Leao, J. Altieri Rivera, Z. Momin, , M. E. Bottazzi

This study develops a yeast-expressed SARS-CoV-2 RBD protein vaccine candidate, RBD219-N1C1, which induces neutralizing antibodies and T-cell responses in mice.

bioRxiv · Nov 4, 2020Immunology

Modeling cannabinoids from a large-scale sample of Cannabis sativa chemotypes

D. Vergara, R. Gaudino, T. Blank, B. Keegan

The paper uses machine learning to cluster Cannabis cultivars based on chemotype and interpolate missing cannabinoid data from a large dataset.

bioRxiv · Feb 28, 2020Plant Biology